FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1972376 · Received January 25, 2011

Report

Report Number
2953200-2011-00174
Event Type
Injury
Date Received
January 25, 2011
Date of Event
September 14, 2012
Report Date
February 27, 2013
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVENT DATE UPDATED.

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: DISSECTION.

Description of Event or Problem · 1

ASA WAS WITHHELD AS A RESULT OF THE BLEED.

Description of Event or Problem · 1

IT IS REPORTED THAT THE PREVIOUSLY REPORTED DISSECTION WAS TREATED WITH AN ENDEAVOR SPRINT RX STENT TO THE LAD. IT IS REPORTED THAT APPROXIMATELY 21 MONTHS POST INDEX PROCEDURE THE PATIENT SUFFERED A GI BLEED. THE PATIENT WAS TREATED WITH MEDICATION, A COLONOSCOPY AND A BLOOD TRANSFUSION. THE PATIENT WAS ON DAPT. IT HAS BEEN ASSESSED THAT THE EVENT WAS NOT RELATED TO THE DEVICE AND THE PATIENT RECOVERED WITH TREATMENT.

Description of Event or Problem · 1

THE PT HAD ONE ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT IMPLANTED TO THE MID RCA DURING THE INDEX PROCEDURE. IT WAS REPORTED THAT A CORONARY ARTERY DISSECTION OCCURRED DURING THE PROCEDURE WHICH REQUIRED INTERVENTION (REVASCULARIZATION). THE DISSECTION EVENT WAS CLASSIFIED AS MILD IN INTENSITY. THE INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE OR THE STUDY DRUG. THE PT RECOVERED WITH TREATMENT AND NO OTHER CLINICAL SEQUELAE WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0004336167

Patients

Seq Age Sex Outcome Treatment
1 66 YR Hospitalization| R RAMIPRIL| ASPIRIN| ASPIRIN, CLOPIDOGREL AND PLAVIX| CLOPIDOGREL| METOPROLOL| OMEPRAZOLE